SCHEMBL5607284

SCHEMBL5607284

Cc1nc(N(CC(C)C)C(=O)O)sc1C(=O)N(CCC(C)C)CCC(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 2/20 0.35
CRHR1 P34998 4/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
KDM4E B2RXH2 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
ALDH1A1 P00352 4/20 0.32
MAPT P10636 4/20 0.32
HPGD P15428 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
LMNA P02545 1/20 0.32
POLB P06746 2/20 0.32
APEX1 P27695 1/20 0.31
LPAR1 Q92633 1/20 0.31
LPAR5 Q9H1C0 1/20 0.31
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5606963 0.81 KMT2A (0.38) KMT2ANPC1RAB9AATMCRHR1
SCHEMBL6834849 0.71 GAA (0.47) KMT2ANPC1RAB9AL3MBTL1ALDH1A1
SCHEMBL5608032 0.68 MAPT (0.48) KMT2ANPC1RAB9AKDM4ETDP1
SCHEMBL773734 0.68 LCK (0.51) CRHR1L3MBTL1ALDH1A1HPGDPOLB
SCHEMBL13584460 0.67 NPC1 (0.45) KMT2ANPC1RAB9AKDM4EALDH1A1
SCHEMBL6834770 0.67 CHRNA7 (0.49) KMT2AKDM4EALDH1A1MAPTPOLB
SCHEMBL4719766 0.62 CA1 (0.41) KDM4EALDH1A1LPAR1LPAR5CYP2C19
SCHEMBL12687787 0.59 MLYCD (0.44) KMT2AKDM4EHPGDLMNALPAR1
SCHEMBL5607987 0.59 ALDH1A1 (0.54) KMT2ANPC1RAB9ACRHR1L3MBTL1
SCHEMBL13584825 0.59 RAB9A (0.39) KMT2ANPC1RAB9AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758564-A2 SYNERGISTIC METHODS AND COMPOSITIONS FOR TREATING CANCER Brystol-Myers Squibb Company (US) 2007-03-07 EP claimed
WO-2005094376-A2 SYNERGISTIC METHODS AND COMPOSITIONS FOR TREATING CANCER BRISTOL-MYERS SQUIBB COMPANY (US) 2005-10-13 WO claimed